Header for print stylesheet
Go

Venture Capital Funds

In our cooperation with (corporate) Venture Capitalists and DSM Venturing, the challenge is to develop good relationships, combine resources and to share leads as well as technical and business know-how.

Cooperation with Venture Capitalists can be:

  • Investments in Venture Capital funds
  • Co-investments with Venture Capitalists
  • The sharing of dealflow
  • The combining of due diligence efforts

At the moment we work together with the following Venture Capital funds:

Ampersand Ventures - Boston, USA

Funds: AMP 1995 and 1999

Specialty materials and chemicals, life sciences, IT and communication.

Burrill & Company - San Francisco, USA

Funds: Nutraceuticals and Life Science Capital Funds

Entire spectrum of life sciences, including human healthcare biotechnology, agricultural biotechnology, nutraceuticals, human healthcare diagnostics and industrial biotechnology (biomaterials and bioprocesses).

Emerald Technology Ventures - Zürich, Switzerland

Funds: ETV II

Innovative technologies in energy, materials and water.

Life Science Partners - Amsterdam, The Netherlands

Fund: LSP II

Human life sciences.

Millenium Materials Technologies Funds - Tel Aviv, Israel

Fund: MMT II

Advanced materials in the fields of nano-technology, polymer technologies, bio-materials, energy & environmental technologies, industrial chemistry and novel crystals.

NGEN - Santa Barbara, USA

Fund: NGEN enabling technologies fund

Polymers and biomaterials, displays and electronic materials technologies,computer simulation technologies, energy and environment,telecommunications technologies.

Sherbrooke Capital - Newton Lower Falls, USA

Fund: Health & Wellness II

Product, service and technology innovations in the emerging area of health and wellness.

footer for print stylesheet